Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | — | — |
No additional AE; Nurse called to report a Patient was given a dose of PROQUAD on 12/31/2024 and another dose on 2/4/2025. Patient received her 1st dose at normal dosing schedule on unknown date, however received 3 doses in total accidentally; This spontaneous report was received from nurse and refers to a 4-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, administered for prophylaxis (dose, strength, lot #, expiry date, and route of administration were not provided). On 31-DEC-2024, the patient was vaccinated with the second dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, administered for prophylaxis (dose, strength, lot #, expiry date, and route of administration were not provided). On 04-FEB-2025, the patient was vaccinated with the third dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection 0.5 milliliter, lot # Y017206 with expiration date of 13-APR-2026, administered for prophylaxis (dose, strength, lot #, expiry date, and route of administration were not provided) (extra dose administered). No additional adverse event (AE) was reported.